Healthcare -
Biotechnology - NASDAQ - US
$ 11.17
-1.97 %
$ 552 M
Market Cap
-3.04
P/E
KALV - TOTAL LIABILITIES
Total Liabilities KALV - KalVista Pharmaceuticals, Inc.
28.8 M
LAST VALUE
23.86%
2 YEAR CAGR
6.14%
5 YEAR CAGR
-4.10%
10 YEAR CAGR